News & Insights

In the News

March 5, 2019 - Source: CNBC

Jim Woolery, King & Spalding’s head of M&A and Corporate Governance, discusses the impact of Wellington’s public vote on the Bristol-Myers / Celgene transaction with CNBC’s David Faber


King & Spalding on CNBC

Icon video